Ruoxiang Wang

4.0k total citations
86 papers, 3.2k citations indexed

About

Ruoxiang Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruoxiang Wang has authored 86 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 39 papers in Oncology and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruoxiang Wang's work include Prostate Cancer Treatment and Research (23 papers), Cancer Cells and Metastasis (19 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Ruoxiang Wang is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Cancer Cells and Metastasis (19 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Ruoxiang Wang collaborates with scholars based in United States, China and Canada. Ruoxiang Wang's co-authors include Haiyen E. Zhau, Leland W.K. Chung, Fray F. Marshall, Yufang Shi, Jianchun Xu, Gina Chia‐Yi Chu, Xiaojian Yang, Nicola J. Mabjeesh, Chunmeng Shi and Majd Zayzafoon and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Ruoxiang Wang

82 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruoxiang Wang United States 35 1.6k 1.1k 904 777 482 86 3.2k
Robert A. Sikes United States 31 1.6k 1.0× 956 0.9× 1.3k 1.4× 608 0.8× 216 0.4× 71 3.3k
Jonathan M. Kurie United States 31 2.2k 1.3× 1.6k 1.4× 1.2k 1.3× 1.2k 1.5× 227 0.5× 73 4.0k
Masahiro Inoue Japan 23 2.0k 1.2× 1.3k 1.2× 652 0.7× 1.3k 1.6× 374 0.8× 49 3.9k
Zhenhe Suo Norway 32 1.8k 1.1× 1.3k 1.1× 447 0.5× 872 1.1× 187 0.4× 107 3.1k
Ranjit S. Bindra United States 33 2.6k 1.6× 1.3k 1.2× 642 0.7× 1.4k 1.7× 242 0.5× 122 4.1k
Luisa M. Solis United States 28 1.8k 1.1× 831 0.7× 594 0.7× 662 0.9× 151 0.3× 68 2.9k
Jinyun Liu United States 22 1.9k 1.2× 936 0.8× 496 0.5× 922 1.2× 200 0.4× 40 3.3k
François Lamoureux France 31 1.6k 0.9× 830 0.7× 717 0.8× 567 0.7× 131 0.3× 73 2.5k
Balaji Krishnamachary United States 31 2.4k 1.5× 927 0.8× 547 0.6× 2.1k 2.7× 487 1.0× 87 4.4k
Michael H. Muders Germany 30 1.3k 0.8× 904 0.8× 554 0.6× 502 0.6× 395 0.8× 79 2.7k

Countries citing papers authored by Ruoxiang Wang

Since Specialization
Citations

This map shows the geographic impact of Ruoxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoxiang Wang more than expected).

Fields of papers citing papers by Ruoxiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoxiang Wang. The network helps show where Ruoxiang Wang may publish in the future.

Co-authorship network of co-authors of Ruoxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoxiang Wang. A scholar is included among the top collaborators of Ruoxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoxiang Wang. Ruoxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yin, Liyuan, Yi Zhang, Lijuan Yin, et al.. (2021). Novel Mitochondria-Based Targeting Restores Responsiveness in Therapeutically Resistant Human Lung Cancer Cells. Molecular Cancer Therapeutics. 20(12). 2527–2538. 6 indexed citations
3.
Yin, Liyuan, Peizhen Hu, Xianping Shi, et al.. (2020). Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction. Scientific Reports. 10(1). 1216–1216. 18 indexed citations
4.
Wang, Ruoxiang, Gina Chia‐Yi Chu, Stefan Mrđenović, et al.. (2016). Cultured circulating tumor cells and their derived xenografts for personalized oncology. Asian journal of urology. 3(4). 240–253. 35 indexed citations
5.
Chu, Gina Chia‐Yi, Haiyen E. Zhau, Ruoxiang Wang, et al.. (2014). RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocrine Related Cancer. 21(2). 311–326. 68 indexed citations
6.
Zhang, Dong, Dalin He, Yan Xue, et al.. (2011). PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway. Cancer Research. 71(6). 2193–2202. 37 indexed citations
7.
Shehata, Bahig M., James M. Elmore, Charlotte K. Steelman, et al.. (2011). Immunohistochemical Characterization of Sonic Hedgehog and its Downstream Signaling Molecules During Human Penile Development. Fetal and Pediatric Pathology. 30(4). 244–251. 6 indexed citations
8.
Yang, Xiaojian, Chunmeng Shi, Rong Tong, et al.. (2010). Near IR Heptamethine Cyanine Dye–Mediated Cancer Imaging. Clinical Cancer Research. 16(10). 2833–2844. 259 indexed citations
9.
Zhang, Shumin, Haiyen E. Zhau, Adeboye O. Osunkoya, et al.. (2010). Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Molecular Cancer. 9(1). 9–9. 92 indexed citations
10.
He, Huiguang, Jianchun Xu, Peter S. Nelson, et al.. (2010). Differential expression of the α2 chain of the interleukin‐13 receptor in metastatic human prostate cancer ARCaPM cells.. The Prostate. 70(9). 993–1001. 8 indexed citations
11.
Josson, Sajni, Yasuhiro Matsuoka, Leland W.K. Chung, Haiyen E. Zhau, & Ruoxiang Wang. (2009). Tumor–stroma co-evolution in prostate cancer progression and metastasis. Seminars in Cell and Developmental Biology. 21(1). 26–32. 111 indexed citations
12.
He, Hui, Xiaojian Yang, Alec J. Davidson, et al.. (2009). Progressive epithelial to mesenchymal transitions in ARCaPE prostate cancer cells during xenograft tumor formation and metastasis. The Prostate. 70(5). 518–528. 31 indexed citations
13.
Odero‐Marah, Valerie, Ruoxiang Wang, Gina Chia‐Yi Chu, et al.. (2008). Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Research. 18(8). 858–870. 111 indexed citations
14.
Amir, Sharon, Ruoxiang Wang, Haim Matzkin, Jonathan W. Simons, & Nicola J. Mabjeesh. (2006). MSF-A Interacts with Hypoxia-Inducible Factor-1α and Augments Hypoxia-Inducible Factor Transcriptional Activation to Affect Tumorigenicity and Angiogenesis. Cancer Research. 66(2). 856–866. 53 indexed citations
15.
Xu, Jianchun, Ruoxiang Wang, Valerie Odero‐Marah, et al.. (2006). Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. The Prostate. 66(15). 1664–1673. 115 indexed citations
16.
Sun, Shi‐Yong, Zhongmei Zhou, Ruoxiang Wang, Haian Fu, & Fadlo R. Khuri. (2004). The farnesyltransferase inhibitor lonafarnib induces growth arrest or apoptosis of human lung cancer cells without downregulation of Akt. Cancer Biology & Therapy. 3(11). 1092–1098. 28 indexed citations
17.
Yeung, Fan, Ching‐Hua Yeh, Jennifer J. Westendorf, et al.. (2002). Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells. Journal of Biological Chemistry. 277(4). 2468–2476. 95 indexed citations
18.
Wang, Ruoxiang, Liying Zhang, Xiaoren Zhang, et al.. (2002). Regulation of activation-induced receptor activator of NF-κB ligand (RANKL) expression in T cells. European Journal of Immunology. 32(4). 1090–1098. 69 indexed citations
19.
Wang, Ruoxiang, Liying Zhang, Xiaoren Zhang, et al.. (2001). Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-κB Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-α During T Cell Activation. The Journal of Immunology. 166(3). 1983–1990. 29 indexed citations
20.
Hwang, David, et al.. (1995). Direct Automated Sequencing of Single λ-Phage Plaques by Exponential Amplification Sequencing. Analytical Biochemistry. 231(2). 460–463. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026